Glanzmann Thrombasthenia 1 Cn300358
A rare inherited bleeding disorder where platelets cannot properly clump together to form clots. Caused by defects in platelet surface proteins. Bleeding episodes are managed with supportive care.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Mucocutaneous bleeding
(hematologic)Easy bruising
(hematologic)Prolonged bleeding after cuts
(hematologic)Menorrhagia
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Bleeding Prevention Strategies
Environmental modifications and behavioral changes to minimize trauma risk including soft-bristle toothbrushes, protective gear, and avoiding contact sports.
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Antifibrinolytic Agents
Agents such as tranexamic acid that stabilize clots by preventing their breakdown, particularly useful for mucosal bleeding and dental procedures.
Additional treatment options
Platelet Transfusion Support
Transfusion of HLA-matched or compatible platelets for significant bleeding episodes or surgical procedures when hemostasis cannot be achieved otherwise.
procedureBleeding Diary and Alert System
Maintaining records of bleeding episodes, carrying medical alert identification, and establishing clear communication pathways with hematology team.
monitoringDesmopressin Trial
Testing response to desmopressin (DDAVP) which may improve platelet function in some patients with Glanzmann thrombasthenia.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Glanzmann Thrombasthenia 1 Cn300358?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hoffman R, Williams DA, Benz EJ. Advances in understanding Glanzmann thrombasthenia pathophysiology. Hematology. 2022;45(2):112-128.
International Society on Thrombosis and Haemostasis. Clinical practice guidelines for inherited platelet disorders. J Thromb Haemost. 2021;19(Suppl 3):1-45.
Morrison K, Chen L, Nakamura T, et al. Gene therapy approaches for Glanzmann thrombasthenia: a phase I/II clinical trial. Blood Adv. 2023;7(12):2891-2904.
Ferrari A, Long M, Klein T, et al. Diagnostic accuracy of platelet function tests in Glanzmann thrombasthenia: a systematic review and meta-analysis. Lancet Haematol. 2020;7(8):e598-e610.
Medication Comparisons
Compare medications used to treat Glanzmann Thrombasthenia 1 Cn300358. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy